Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/37125
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNikolic-Paterson D.J.en
dc.contributor.authorHou W.en
dc.contributor.authorLeong K.G.en
dc.contributor.authorOzols E.en
dc.contributor.authorTesch G.H.en
dc.contributor.authorMa F.Y.en
dc.date.accessioned2021-05-14T12:37:09Zen
dc.date.available2021-05-14T12:37:09Zen
dc.date.copyright2018en
dc.date.created20180220en
dc.date.issued2018-02-20en
dc.identifier.citationClinical and Experimental Pharmacology and Physiology. 45 (3) (pp 250-260), 2018. Date of Publication: March 2018.en
dc.identifier.issn0305-1870en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/37125en
dc.description.abstractCyclophilin D (CypD) is an important component in mitochondrial-dependent tubular cell death in acute kidney injury. However, it is not known whether CypD contributes to tubular cell damage in chronic interstitial fibrosis. We investigated this question in the unilateral ureter obstruction (UUO) model of renal interstitial fibrosis. Groups of CypD-/- and wild type (WT) mice were killed 7 or 12 days after UUO surgery. The significant tubular cell apoptosis seen in WT UUO was significantly reduced in CypD-/- UUO based on TUNEL and cleaved caspase 3 staining. Other markers of tubular cell damage; loss of E-cadherin and AQP1 expression, were also reduced in the CypD-/- UUO kidney. This reduced tubular damage was associated with less inflammation and a partial protection against loss of peritubular capillaries. The prominent accumulation of alpha-SMA+ myofibroblasts and interstitial collagen deposition seen in WT UUO was significantly reduced in CypD-/- UUO on day 12, but not day 7. Activation of several pro-fibrotic signalling pathways (p38 MAPK, JNK and Smad3) was unaltered in CypD-/- UUO, arguing that CypD acts independently to promote renal fibrosis. CypD deletion in cultured tubular cells attenuated oxidative stress-induced pro-inflammatory, pro-fibrotic and apoptotic responses; however, responses to angiotensin II and LPS were unaffected. In contrast, CypD deletion in cultured renal fibroblasts did not affect PDGF-induced proliferation or TGF-beta1-induced collagen I expression, suggesting no direct role of CypD in the fibroblast response. In conclusion, we have identified a role for CypD in chronic tubular cell damage and in the development of renal interstitial fibrosis.Copyright © 2017 John Wiley & Sons Australia, Ltden
dc.languageEnglishen
dc.languageenen
dc.publisherBlackwell Publishingen
dc.relation.ispartofClinical and Experimental Pharmacology and Physiologyen
dc.titleCyclophilin D promotes tubular cell damage and the development of interstitial fibrosis in the obstructed kidney.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/1440-1681.12881en
dc.publisher.placeAustraliaen
dc.identifier.orcidNikolic-Paterson, David J; ORCID: http://orcid.org/0000-0001-5734-2931en
dc.identifier.pubmedid29230844 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29230844]en
dc.identifier.source620649964en
dc.identifier.institution(Hou) Department of Nephrology, Xinqiao Hospital, Chongqing, China (Leong, Ozols, Tesch, Nikolic-Paterson, Ma) Department of Nephrology, Monash Health, Monash Medical Centre, Clayton, VIC, Australia (Leong, Ozols, Tesch, Nikolic-Paterson, Ma) Monash University Centre for Inflammatory Diseases, Monash Medical Centre, Clayton, VIC, Australiaen
dc.description.addressD.J. Nikolic-Paterson, Department of Nephrology, Monash Health, Monash Medical Centre, Clayton, VIC, Australia. E-mail: david.nikolic-paterson@monash.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2019 Elsevier B.V., All rights reserved.en
dc.subect.keywordsapoptosis cyclophilin D endothelium fibrosis tubular epithelial cellsen
dc.identifier.authoremailNikolic-Paterson D.J.; david.nikolic-paterson@monash.eduen
dc.description.grantOrganization: (NHMRC) *National Health and Medical Research Council* Organization No: 501100000925 Country: Australia No: 81170648 Organization: (NSFC) *National Natural Science Foundation of China* Organization No: 501100001809 Country: Chinaen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
crisitem.author.deptNephrology-
Appears in Collections:Articles
Show simple item record

Page view(s)

36
checked on Sep 14, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.